Mark Sheptoff Financial Planning LLC raised its position in Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS by 41.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,985 shares of the technology company's stock after purchasing an additional 8,485 shares during the period. Celestica makes up about 1.4% of Mark Sheptoff Financial Planning LLC's investment portfolio, making the stock its 19th biggest holding. Mark Sheptoff Financial Planning LLC's holdings in Celestica were worth $2,675,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Peregrine Capital Management LLC bought a new stake in shares of Celestica in the 4th quarter valued at $30,000. R Squared Ltd acquired a new position in Celestica in the fourth quarter valued at about $51,000. IFP Advisors Inc increased its holdings in shares of Celestica by 122.7% in the fourth quarter. IFP Advisors Inc now owns 668 shares of the technology company's stock worth $62,000 after acquiring an additional 368 shares in the last quarter. Private Trust Co. NA raised its position in shares of Celestica by 480.0% during the third quarter. Private Trust Co. NA now owns 870 shares of the technology company's stock worth $44,000 after purchasing an additional 720 shares during the period. Finally, UMB Bank n.a. lifted its holdings in shares of Celestica by 43.6% during the 4th quarter. UMB Bank n.a. now owns 949 shares of the technology company's stock valued at $88,000 after purchasing an additional 288 shares in the last quarter. 67.38% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Celestica
In other Celestica news, Director Michael Wilson sold 25,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $98.73, for a total transaction of $2,468,250.00. Following the transaction, the director now owns 1,784 shares in the company, valued at $176,134.32. This trade represents a 93.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Todd C. Cooper sold 9,538 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $127.54, for a total transaction of $1,216,476.52. Following the completion of the sale, the president now directly owns 175,426 shares of the company's stock, valued at approximately $22,373,832.04. The trade was a 5.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 959,381 shares of company stock worth $119,142,019 over the last ninety days. Insiders own 1.00% of the company's stock.
Celestica Stock Performance
CLS traded down $1.83 during trading hours on Friday, reaching $82.56. The company's stock had a trading volume of 3,977,992 shares, compared to its average volume of 2,870,805. The company's 50-day moving average is $108.09 and its 200-day moving average is $88.07. Celestica Inc. has a 52 week low of $40.25 and a 52 week high of $144.27. The firm has a market cap of $9.57 billion, a PE ratio of 22.07 and a beta of 2.21. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.87 and a current ratio of 1.47.
Wall Street Analyst Weigh In
A number of brokerages recently commented on CLS. Canaccord Genuity Group raised their price objective on shares of Celestica from $77.00 to $110.00 and gave the stock a "buy" rating in a report on Friday, December 20th. TD Securities increased their target price on shares of Celestica from $70.00 to $107.00 and gave the stock a "buy" rating in a report on Tuesday, January 28th. Cibc World Mkts raised shares of Celestica from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 31st. Royal Bank of Canada boosted their price target on shares of Celestica from $115.00 to $140.00 and gave the stock an "outperform" rating in a research report on Friday, January 31st. Finally, CIBC upgraded Celestica from a "neutral" rating to a "sector outperform" rating and set a $150.00 price objective for the company in a report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Celestica presently has a consensus rating of "Moderate Buy" and an average target price of $110.83.
View Our Latest Analysis on Celestica
About Celestica
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Further Reading

Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.